822 augmented apoptosis inducing gene therapy for HCC by p53 under control of AFP promoter in combination with a selectively replication competent oncolytic adenovirus and chemotherapeutic agent

822 Augmented Apoptosis Inducing Gene Therapy for HCC by p53 under Control of AFP Promoter in Combination with a Selectively Replication Competent Oncolytic Adenovirus and Chemotherapeutic Agent Molec[.]

Molecular Therapy Vol 5, No 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy

S268

 """

820 Conditionally Replicaitive Adenovirus, AdGRPE1

Shows the Specific Propagation and Oncolytic Effect to

GRP Positive SCLC Cell Lines

Koichi Takayama, 1,2 Paul N Reynolds, 1,2 Yasuo Adachi, 1,2 Toshiro

Seki, 1,2 Masato Yamamoto, 1,2 Victor N Krasnykh, 1,2 David T Curiel 1,2

1 Division of Human Gene Therapy, Departments of Medicine,

Pathology, and Surgery; 2 The Gene Therapy Center, University of

Alabama at Birmingham, Birmingham, AL, United States.

821 Conditionally Replicative Adenovirus, AdVEGFE1 Has a Possibility for Universal

Has a Possibility for Universal Application in V Application in V Application in Various arious Cancer T

Cancer Treatments reatments

Koichi Takayama, 1,2 Paul N Reynolds, 1,2 Yasuo Adachi, 1,2 Minghui Wang, 1,2 Victor N Krasnykh, 1,2 David T Curiel 1,2

1 Division of Human Gene Therapy, Departments of Medicine, Pathology, and Surgery; 2 The Gene Therapy Center, University of Alabama at Birmingham, Birmingham, AL, United States.

822 Augmented Apoptosis-Inducing Gene Therapy for HCC by p53 under Control of AFP Promoter in

Combination with a Selectively Replication-Competent Oncolytic Adenovirus and Chemotherapeutic Agent

Yasuyuki Yamada, 1 Minoru Takahashi, 1 Yasushi Sato, 1 Junki Fukaura, 1 Tsutomu Sato, 1 Satoshi Iyama, 1 Takatomi Oku, 1 Tetsuya Sumiyoshi, 1 Tamotsu Sagawa, 1 Yoshiro Niitsu 1

1 4th Department of Internal Medicine, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.

Molecular Therapy Vol 5, No 5, May 2002, Part 2 of 2 Parts

!"!



823 Deletion of E1B 19k Improves the Efficacy of a

Midkine-Promoter Based Conditionally Replicative

Adenovirus for Neuroblastoma Cells

Yasuo Adachi, 1 Paul N Reynolds, 1,2 Koichi Takayama, 1 Minghui

Wang, 1 Liodmila Kaliberova, 1 David T Curiel 1,2

1 Division of Human Gene Therapy, Departments of Medicine,

Pathology, and Surgery; 2 the Gene Therapy Center, University of

Alabama at Birmingham, Birmingham, Alabama, United States.

 !"!

824 NIRF Imaging and T

824 NIRF Imaging and Tumor Cell umor Cell umor Cell Apoptosis Using Apoptosis Using HSV V

HSV Vector-Mediated Gene Delivery to Gliomas ector-Mediated Gene Delivery to Gliomas

Khalid Shah, 1,2 Ching-Hsuan Tung, 2 Erik Slootweg, 1 Ralph Weissleder, 2 Xandra O Breakefield 1

1 Molecular Neurogenetics Unit, Department of Neurology, MGH East, Harvard Medical School, Charlestown, Massachusetts, United States; 2 Center for Molecular Imaging Research, Department of Radiology, Harvard Medical School, Charlestown, Massachusetts, United States.